Lexiva (Royalty right of Vertex Pharmaceuticals) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Asset Purch.

  • Financing Rounds
  • 2

Lexiva (Royalty right of Vertex Pharmaceuticals) General Information

Description

An HIV protease inhibitor medicine. The medicine is used for the treatment of HIV or AIDS infection and is currently approved for use in approximately 45 countries.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Corporate Office
  • 50 Northern Avenue
  • Boston, MA 02210
  • United States
Primary Industry
Pharmaceuticals
Corporate Office
  • 50 Northern Avenue
  • Boston, MA 02210
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Lexiva (Royalty right of Vertex Pharmaceuticals) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Lexiva (Royalty right of Vertex Pharmaceuticals)‘s full profile, request access.

Request a free trial

Lexiva (Royalty right of Vertex Pharmaceuticals) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Lexiva (Royalty right of Vertex Pharmaceuticals)‘s full profile, request access.

Request a free trial

Lexiva (Royalty right of Vertex Pharmaceuticals) FAQs

  • Where is Lexiva (Royalty right of Vertex Pharmaceuticals) headquartered?

    Lexiva (Royalty right of Vertex Pharmaceuticals) is headquartered in Boston, MA.

  • What industry is Lexiva (Royalty right of Vertex Pharmaceuticals) in?

    Lexiva (Royalty right of Vertex Pharmaceuticals)’s primary industry is Pharmaceuticals.

  • Is Lexiva (Royalty right of Vertex Pharmaceuticals) a private or public company?

    Lexiva (Royalty right of Vertex Pharmaceuticals) is a Private company.

  • What is Lexiva (Royalty right of Vertex Pharmaceuticals)’s current revenue?

    The current revenue for Lexiva (Royalty right of Vertex Pharmaceuticals) is .

  • Who are Lexiva (Royalty right of Vertex Pharmaceuticals)’s investors?

    HealthCare Royalty Partners and Vertex Pharmaceuticals have invested in Lexiva (Royalty right of Vertex Pharmaceuticals).

  • When was Lexiva (Royalty right of Vertex Pharmaceuticals) acquired?

    Lexiva (Royalty right of Vertex Pharmaceuticals) was acquired on 01-May-2017.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »